Elevance Health, Inc. ELV

396.09 (2.16) (0.54%) as of 25 Sep
Market cap
$86.4B
P/E
17.6×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
15.55 15.74 18.50 16.38 17.93 18.75 20.26 19.02 14.40 13.96
P/S ratio
0.44 0.66 0.74 0.74 0.66 0.82 0.77 0.66 0.48 0.39
P/FCF ratio
14.02 17.41 25.88 15.48 8.33 15.53 16.63 16.70 18.78 24.74
P/Operating CF
136.15 (45.43) 146.40 58.15 21.12 67.59 (79.40) (38.02) 121.07 934.80
P/B ratio
1.50 2.23 2.38 2.43 2.43 3.13 3.32 2.87 2.06 1.78
Price to Tangible BV
0.00 0.00 0.00 30.21 38.29 87.95 73.85 29.61 81.02 17.52
EV/Sales
0.34 0.59 0.69 0.68 0.57 0.74 0.70 0.59 0.46 0.37
EV/EBITDA
4.71 8.97 9.06 9.02 8.50 10.16 10.87 9.67 7.79 7.69
EV/Operating CF
8.91 12.59 16.49 11.70 6.53 12.28 13.11 12.59 14.06 17.32
EV/FCF
10.85 15.53 24.10 14.23 7.22 14.12 15.19 15.00 17.94 23.41
Quick Ratio
1.52 1.45 1.46 1.53 1.42 1.33 1.27 1.30 1.32 1.41
Current Ratio
1.61 1.55 1.56 1.66 1.55 1.47 1.40 1.44 1.45 1.54
Net Debt/EBITDA
(1.38) (1.09) (0.67) (0.79) (1.30) (1.02) (1.03) (1.09) (0.36) (0.44)
Debt/Assets
23.49% 26.45% 25.24% 25.03% 23.13% 23.35% 23.21% 22.85% 26.41% 26.25%
Debt/Equity
0.61 0.70 0.63 0.61 0.60 0.63 0.66 0.63 0.75 0.72
Asset Turnover
1.34 1.33 1.30 1.40 1.49 1.51 1.56 1.62 1.57 1.67
Operating CF/Net income
1.32 1.09 1.02 1.26 2.34 1.36 1.43 1.35 0.97 0.76
Capex/Depreciation
(0.64) (0.89) (1.07) (0.95) (0.88) (0.83) (0.69) (0.74) (0.90) (0.72)
Interest Coverage
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE
10.26% 14.89% 13.63% 15.95% 14.08% 17.77% 16.27% 15.81% 14.80% 13.25%
ROA
3.90% 5.67% 5.28% 6.45% 5.57% 6.69% 5.89% 5.66% 5.30% 4.75%
ROIC
19.89% 15.50% 15.27% 16.51% 19.60% 21.31% 20.40% 19.57% 15.10% 12.74%
Return on Tangible Assets
16.47% 25.48% 24.85% 25.80% 23.11% 30.55% 29.12% 26.49% 25.99% 21.25%
Average Days of Receivables
36.84 35.65 36.90 36.39 32.82 35.38 37.40 38.06 39.32 39.49
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
14.80% 14.05% 15.22% 12.82% 14.32% 11.48% 11.29% 0.00% 0.00% 0.00%
Intangible Assets out of Total Assets
0.39 0.39 0.41 0.38 0.36 0.36 0.34 0.33 0.35 0.33
Share Based Compensation of Revenue
0.19% 0.19% 0.25% 0.28% 0.23% 0.18% 0.17% 0.17% 0.11% 0.14%
Graham Net Nets
(0.15) (0.13) (0.13) (0.09) (0.10) (0.09) (0.09) (0.08) (0.19) (0.18)
Graham Number
140.66 180.96 187.96 226.99 230.96 287.09 290.57 307.57 320.97 333.30
Earnings Yield
6.43% 6.35% 5.41% 6.11% 5.58% 5.33% 4.94% 5.26% 6.94% 7.17%
Free Cash Flow Yield
7.13% 5.74% 3.86% 6.46% 12.00% 6.44% 6.01% 5.99% 5.33% 4.04%
Revenue per Share
322.80 344.32 356.86 407.88 485.91 568.66 652.48 726.32 763.97 888.95
Operating CF per Share
12.44 16.00 14.83 23.72 42.62 34.31 35.00 34.17 25.07 19.15
Capex per Share
(2.22) (3.02) (4.68) (4.22) (4.07) (4.46) (4.80) (5.49) (5.42) (4.98)
Free Cash Flow per Share
10.22 12.98 10.15 19.51 38.54 29.85 30.20 28.68 19.65 14.17
Cash per Share
90.54 95.82 88.12 100.28 122.54 135.47 142.88 154.17 149.68 161.23
Shareholders Equity per Share
95.48 101.35 110.58 124.18 132.37 148.19 151.38 167.04 178.79 196.54
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
95.48 101.35 110.58 124.18 132.37 148.19 151.38 167.04 178.79 196.54
Free Cash Flow
2,686.00 3,394.00 2,619.00 4,984.00 9,667.00 7,277.00 7,247.00 6,765.00 4,552.00 3,174.00
Working Capital
13,020.50 12,907.00 12,356.00 15,501.00 16,298.00 16,237.00 15,921.00 18,238.00 18,361.00 21,966.00
Capital Expenditures
(584.00) (791.00) (1,208.00) (1,077.00) (1,021.00) (1,087.00) (1,152.00) (1,296.00) (1,256.00) (1,116.00)
Net Current Asset Value
(5,667.80) (7,774.00) (8,709.00) (6,692.00) (7,665.00) (10,210.00) (10,808.00) (9,494.00) (16,521.00) (14,467.00)
EV/EBIT
5.52 10.57 10.82 10.53 9.89 11.66 13.03 11.60 8.98 9.16
Capex to Sales
0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01
Net Profit Margin
2.91% 4.27% 4.07% 4.61% 3.75% 4.44% 3.76% 3.49% 3.38% 2.84%
Price to Operating Income
7.13 11.86 11.62 11.46 11.41 12.82 14.26 12.92 9.40 9.68
Other line items
Depreciation/Fixed assets
0.46 0.41 0.41 0.36 0.33 0.33 0.39 0.40 0.30 0.33
Cash ROIC
2.01% 2.86% 1.57% 3.82% 8.58% 4.84% 4.32% 3.68% 1.08% (0.35%)
Accounts Receivable Turnover
10.67 10.37 10.17 10.58 11.42 11.36 10.62 10.11 9.58 9.81
Accounts Payable Turnover
5.78 5.72 5.56 6.51 6.49 6.42 6.53 6.40 6.45 7.20
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Average Days of Payables
65.93 66.69 64.40 56.81 63.41 59.47 59.68 59.33 56.18 52.59
Days of Inventory on Hand
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Average Receivables
7,953.45 8,680.05 9,052.50 9,851.00 10,674.50 12,199.00 14,742.00 16,954.50 18,468.00 20,306.50
Average Payables
11,553.20 12,635.90 12,942.00 12,862.50 14,946.00 17,670.00 19,845.50 22,112.00 22,847.00 23,539.50
Average Assets
63,400.45 67,811.55 71,055.50 74,512.00 82,034.00 92,037.50 100,107.50 105,841.50 112,908.50 119,191.50
Average Common Equity
24,072.25 25,801.70 27,522.00 30,134.50 32,463.50 34,663.50 36,229.00 37,867.50 40,415.50 42,726.00

Fold the line items

Columns are period end dates